In vitro and in vivo transdermal studies of atenolol using iontophoresis

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 1, 2008, Pages 29-36

  Inal, Özge ^a   Kiliçarslan, Müge ^a   Ari, Nuray ^a   Baykara, Tamer ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Atenolol; Iontophoresis; Oleic acid; Polymethyl methacrylates; Transdermal drug delivery

Indexed keywords

2 PROPANOL; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ACETONE; ATENOLOL; EUDRAGIT; EUDRAGIT E 100; EUDRAGIT NE 40 D; METHANOL; OLEIC ACID; TRIACETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIRECT CURRENT; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ELECTRODE; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; IONTOPHORESIS; MALE; NONHUMAN; PH; RAT;

2-PROPANOL; ACETONE; ACRYLATES; ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ATENOLOL; DIFFUSION; IONTOPHORESIS; MALE; METHANOL; OLEIC ACID; POLYMERS; POLYMETHACRYLIC ACIDS; RATS; RATS, WISTAR; SKIN ABSORPTION; SOLVENTS; TRIACETIN;

EID: 42549148801     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cho C.W., Shin S.C.: Int. J. Pharm. 287, 67 (2004).
2. Modamio, P., Lastra, C.F., Marino E.L.: Int. J. Pharm. 194, 249 (2000).
3. Ghosh T.K., Chiao C.S., Gokhale R.D.: J. Pharm. Pharmacol. 24, 218 (1993).
4. Demou, J.S., Sidhom, M.B., Plakogiannis, F.M.: Pharm. Acta Helvetiae 68, 215 (1994).
5. Gupta S.P. Jain S.K.: Drug Delivery 11, 281 (2004).
6. Kalia, Y.N., Guy, R.H.: J. Controlled Rel. 44, 33 (1997).
7. Denet A.R., Ucakar B., Preat V.P.: Pharm. Res. 20, 1946 (2003).
8. Banga A.K.: in: Handbook of Pharmaceutical Controlled Release Technology, Wise D.L. Ed., p.567-581. Marcel Dekker, New York 2000.
9. Hirsch A.C., Upasani R.S., Banga A.K.: J. Controlled Rel. 103, 113 (2005).
10. Burnette R.R., Ongpipattanakul B.: J. Pharm. Sci. 76, 765 (1987).
11. Jacobsen J.: J. Controlled Rel. 70, 83 (2001).
12. Dittgen M.: Drug. Dev. Ind. Pharm. 11, 269 (1985).
13. Acartürk F., Şencan A.: Int. J. Pharm. 131, 183 (1996).
14. Minghetti P., Cilurzo F., Casiraghi A., Montanari L.: Int. J. Pharm. 190, 91 (1999).
15. Wong C.F., Yuen K.H., Peh K.K.: Int. J. Pharm. 178, 11 (1999).
16. Lin S.Y., Lin Y.Y., Cheng C.L.: Pharmazie 50, 801 (1995).
17. Bodmeier R., Paeratakul O.: Int. J. Pharm. 59, 197 (1990).
18. Jenquin, M.R., Sarabia, R.E., Liebowitz, S.M., McGinity, J.W.: J. Pharm. Sci. 81, 983 (1992).
19. Pongjanyakul T., Prakongpan S., Priprem A.: Drug. Dev. Ind. Pharm. 29, 843 (2003).
20. ICH Harmonised Tripartite Guideline, Validation Of Analytical Procedures: Methodology O2(R1) (2005).
21. Tashiro Y., Sami M., Shichibe S., Kato Y., Hayakawa E., Itoh K.: Biol. Pharm. Bull. 24, 671 (2001).
22. Mehvar R.: J. Pharm. Sci. 78, 1035 (1989).
23. Mehvar R., Gross M.E., Kreamer R.N.: J. Pharm. Sci. 79, 881 (1990).
24. Hubert P.H., Chiap P., Crommen J., et al.: Anal. Chim. Acta 391, 135 (1999).
25. ROEHM Pharma Polymers Catalogue, Formulation technology based on Eudragit E 100 for manufacturing of transdermal therapy systems. RÖHM PHARMA DEGUSSA, 03, 2000.
26. Siepmann J., Lecomte F., Bodmeier R.: J. Controlled Rel. 60, 379 (1999).
27. Aitken-Nichol C., Zhang F., McGinity J.W.: Pharm. Res. 13, 804 (1996).
28. Lin S.Y., Lee C.J., Lin Y.Y.: Pharm. Res. 8, 1137 (1991).
29. Lin S.Y., Chen K.S., Run-Chu L.: J.H. Control Release Rel. 68, 343 (2000).
30. Moneghini M., Carcano A., Zingone G., Perissutti, B.: Int. J. Pharm. 175, 177 (1998).
31. Lin S.Y., Cheng C.L., Perng R.I.: Eur. J. Pharm. Sci. 1, 313 (1994).
32. Gondaliya D., Pundarikakshudu K.: AAPS Pharm. Sci. Tech. 4(1), Article 3 (http://pharmscitech.org) (2003).
33. Kai T., Nakazono M., Kurosaki Y., Nakayama T., Kimura T.: Biol. Pharm. Bull. 16, 801 (1993).
34. Naik A., Pechtold, L., Russell O.P., Guy, R.H.: J. Controlled Rel. 37, 299 (1995).
35. Hadgraft, J.: Eur. J. Pharm. Biopharm. 58, 291 (2004).